Manufacturing - Specialty Pharma

Switzerland-based global pharmaceutical company, Novartis is to acquire Anthos Therapeutics, a US-based, privately held, clinical-stage biopharmaceutical company with abelacimab, a late-stage medicine in development for the prevention...

MoonLake Immunotherapeutics is a Switzerland-based clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational nanobody for the treatment of inflammatory diseases. Founded in...

Angelini Pharma, the Italy-based international pharmaceutical company and part of the Angelini Industries Group, is entering the US market with the acquisition of Nasdaq-listed...

Cinclus Pharma, a clinical stage pharma, is listing its shares on Nasdaq Stockholm looking to raise up to SEK787m (US$75m). The first day of...

ExeVir Bio, a biotech company developing heavy chain-only antibodies, has appointed Michael Garrett as its new CEO, effective 1 December 2024. He will also join ExeVir’s...

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, has held the final close of Sofinnova Biovelocita II,...

International private equity firms, Bain Capital and Cinven, have signed a definitive agreement to sell a majority stake in STADA Arzneimittel, a healthcare and...

Nasdaq listed Bruker Corporation, a manufacturer of scientific instruments for molecular and materials research, is acquiring Chemspeed Technologies, a Swiss provider of vendor-agnostic automated...

Germany-based biotech company, CatalYm, has closed an oversubscribed US$150m Series D financing. Founded in 2016 with support from Forbion and BGV, CatalYm is a...

UK-headquartered global biopharma company GSK has agreed to acquire 100% of the outstanding equity interests (including all options and other incentive equity) in IDRx,...